Although hypertension and a history of palpitations are significant considerations when prescribing mirabegron, the significant potential for cognitive side effects of antimuscarinics do not apply to β-3 agonists and therefore support the use of mirabegron in the older population at this time. Here, IGKV4-1 is linked to Hypertension.